Colgin Mark 4
4 · AspenBio Pharma, Inc. · Filed Jan 21, 2010
Insider Transaction Report
Form 4
Colgin Mark
Chief Scientific Officer
Transactions
- Award
Option -Right to Buy
2010-01-19+50,000→ 50,000 totalExercise: $2.20Exp: 2020-01-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option to purchase 50,000 shares of common stock shall become exercisable as to 33.33% of the shares on each of January 19, 2011 and January 19, 2012, and as to the remaining 33.34% of the shares on January 19, 2013.